Purpose
Lung cancer has the highest mortality rate among all types of cancer in the United States. National Lung Screening Trial (NLST) demonstrated low dose CT (LDCT) for lung cancer screening decreases both lung cancer related mortality and all-cause mortality. Currently, the only CMS approved lung cancer screening registry is the Lung Cancer Screening Registry (LCSR) administered by the American College of Radiology (ACR). We aim to assess access to lung cancer screening services as estimated by the number and distribution of screening facilities participating in the LCSR, by state, and to evaluate state-level covariates that correlate with access.
Method
The ACR LCSR list of participating lung cancer screening facilities was used as a proxy for the availability of lung cancer screening facilities in each state. Additionally, we normalized the number of facilities by state by the number of screening-eligible individuals using BRFSS data. State-level demographics were obtained from the 2015 BRFSS: poverty level, insured population, unemployed, Black and Latino. We obtained state-specific lung cancer incidence and death rates, number of active physician per 100,000 and Medicare expenditure per capita. We performed linear regression models to examine the influence of these state-level covariates on state-level screening facility number using Stata 11. QGIS, an open source geographic information system, was used to map the distribution of lung cancer screening facilities and to estimate the nearest neighbor index, a measure of facility clustering within each state.
Result
As of 11/18/2016, 2,423 facilities participated in the LCSR. When adjusted by the rate of screening-eligible individuals per 100,000, median population-normalized facility number was 15.7 (interquartile rang (IQR) 25%,75% 10.7,19.3). There was a positive independent effect (coefficient=12.87, 95% CI= 10.93–14.8) between state-level number of screening facility and rate of screen-eligible individuals rate per 100,000. There were no significant correlations between numbers of facility and lung cancer outcomes, state demographic characteristics, or physician supply and Medicare expenditure. In most states, facilities are clustered rather than dispersed with a median nearest neighbor index of 0.65 (IQR25%,75% 0.51,0.81).
Conclusion
Facility number correlated with the rate of screening-eligible individuals per 100,000, a measure of the at-risk population. Alignment of screening facility number and distribution with other clinically relevant epidemiologic factors remains a public health opportunity.